A Strong Infusion pumps pipeline –Will it have a significant effect on the market? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.
Included in the report is a lengthy discussion of the strengths and weakness of the field of infusion pumps, as well as the opportunities and threats facing developers. The report includes a forecast of the global infusion pumps market through to 2025, as well as forecasts for three submarkets: • Insulin pumps • Enteral feeding pumps • Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps).
Forecasts from 2015-2025 and other analyses show you commercial prospects This independent, 206-page report guarantees you will remain better informed than your competition. With 128 tables and figures examining the infusion pumps market space, the report gives you a visual, one-stop breakdown of your market. In addition, this report provides analysis of competing technologies, with forecasts to 2025 for the global drug delivery technologies market and the following submarkets: • Oral drug delivery • Inhalation drug delivery • Injectable/implantable drug delivery • Transdermal drug delivery • Ocular drug delivery • Nasal drug delivery
Forecasts from 2015-2025 and other analyses show you commercial prospects Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter’s Five Forces analysis), product profiles and commercial developments. Read the full transcript of one exclusive expert opinion interview from an industry specialist informing your understanding and allowing you to assess prospects for investments and sales, including: – Prof. Charles Clark, Former Associate Dean, Indiana University School of Medicine
Discover how high revenues can go. Our analysis also breaks the main world forecast into geographical markets.
What are the prospects in the leading regions and countries? National markets are also discussed, with forecasts to 2025 provided for the US, EU5 (Germany, UK, France, Italy and Spain), Japan, China, India, Brazil, Russia and South Korea.
There will be growth in both developed and developing pharmaceutical markets. Our analyses show that the emerging markets will achieve high revenue growth by 2025.
Potential for market growth Overall world revenue for infusion pumps will reach $8.09bn in 2015, our work forecasts. We predict strong revenue growth through to 2025. Market entry of novel therapies, increasing conversion from conventional methods for insulin delivery to the use of insulin infusion pumps, and a shift towards homecare will drive sales until 2025. • Discover capabilities, progress, and commercial prospects, helping you stay ahead. • Research and development – assess innovation, trends and possibilities • What about R&D? In this report you will find analyses for a number of pipeline pumps and novel technologies. • Advanced infusion pumps are in great demand, allowing patients safer and more reliable treatments. Our work explains, discussing many issues.
How does Infusion Pumps Market: Prospects for Leading Companies 2015-2025 report help you? In summary, our 206 pages report gives you the following knowledge: • A comprehensive introduction to infusion pumps – discover everything you need to know about their use • Revenue forecasts to 2025 for the leading national markets • Review of R&D pipelines – investigate developmental trends and progress • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market • View an exclusive interview transcript
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the Infusion Pumps market and leading companies. You will find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 World Infusion Pumps Market Highlights 1.2 World Infusion Pumps Market Segmentation 1.3 Why You Should Read This Report 1.4 How This Report Delivers 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report For? 1.7 Methodology 1.8 Frequently Asked Questions (FAQ) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2. Introduction to Infusion Pumps 2.1 What Are Infusion Pumps? 2.2 Types of Infusion 2.3 Types of Pumps 2.3.1 Gravity Controlled Pumps 2.3.2 Positive Displacement Pumps 2.3.2.1 Drip Rate Pumps 2.3.2.2 Volumetric Pumps 2.3.2.3 Syringe Pumps 2.3.2.4 Multi-Channel Pumps 2.3.2.5 Ambulatory Pumps 2.4 History of Infusion Pumps 2.5 What Clinical Settings Will Infusion Pumps Be Useful For? 2.5.1 Infusion Pumps for Diabetes 2.5.2 Infusion Pumps for Chemotherapy 2.5.3 Infusion Pumps for Analgesia 2.5.4 Infusion Pumps for Enteral Feeding 2.5.5 Other Uses for Infusion Pumps 2.6 Advantages and Disadvantages of Infusion Pumps 2.7 Regulation of the Infusion Pump Market 2.7.1 The US Approval and Regulation System 2.7.2 The EU Approval and Regulation System 2.7.2.1 Expected Changes in the New EU Medical Device Regulations 2.7.2.2 Post Marketing Surveillance in the EU 2.8 Japan: Improved Approval Process
3. Infusion Pumps: World Market, 2015-2025 3.1 World Medical Devices Market, 2015-2025 3.2 Infusion Pump Market Definition 3.3 World Infusion Pumps Market, 2014 3.4 World Infusion Pumps Market: Sales Forecast, 2015-2025 3.4.1 The Infusion Pumps Market: Sales Forecast, 2015-2019 3.4.2 The Infusion Pumps Market: Sales Forecast, 2019-2025 3.5 The Infusion Pumps Market: Insulin Pumps Are Market Leaders 3.6 How Will Segmental Market Shares Change to 2025? 3.7 World Infusion Pumps Market: Drivers and Restraints, 2015-2025 3.7.1 Ageing Population and Rising Incidences of Chronic Diseases 3.7.2 Advancement in Infusion Pump Technologies 3.7.3 A Shift towards Home Care 3.7.4 Safety Risk and Stringent Approval Process
4. Leading National Markets, 2015-2025 4.1 Regional Breakdown of World Infusion Pumps Market, 2014 4.2 Infusion Pumps National Market Forecast, 2015-2025 4.2.1 How Will National Market Shares Change to 2025? 4.3 US Infusion Pumps Market, 2014 4.3.1 US Infusion Pumps Market Forecast, 2015-2025 4.4 EU Infusion Pumps Market, 2014 4.4.1 EU Infusion Pumps Market Forecast, 2015-2025 4.4.2 How Will EU Market Shares Change to 2025? 4.4.3 Germany Infusion Pumps Market Forecast, 2015-2025 4.4.4 French Infusion Pumps Market Forecast, 2015-2025 4.4.5 UK Infusion Pumps Market Forecast, 2015-2025 4.4.6 Italian Infusion Pumps Market Forecast, 2015-2025 4.4.7 Spanish Infusion Pumps Market Forecast, 2015-2025 4.5 Japanese Infusion Pumps Market, 2014 4.5.1 Japanese Infusion Pumps Market Forecast, 2015-2025 4.6 Chinese Infusion Pumps Market, 2014 4.6.1 Chinese Infusion Pumps Market Forecast, 2015-2025 4.6.2 China’s 12th Five-Year-Plan (2010-2015) 4.6.3 New Policies Favouring Domestically-Made Medical Devices 4.7 Indian Infusion Pumps Market, 2014 4.7.1 Indian Infusion Pumps Market Forecast, 2015-2025 4.8 Brazilian Infusion Pumps Market, 2014 4.8.1 Brazilian Infusion Pumps Market Forecast, 2015-2025 4.9 South Korean Infusion Pumps Market, 2014 4.9.1 South Korean Infusion Pumps Market Forecast, 2015-2025 4.10 Russian Infusion Pumps Market, 2014 4.10.1 Russian Infusion Pumps Market Forecast, 2015-2025
5. Insulin Pumps Submarket, 2015-2025 5.1 Introduction to Insulin Pumps 5.1.1 Insulin in Insulin Pumps 5.1.1.1 Bolus Infusion 5.1.1.2 Basal Infusion 5.1.2 Advantages and Disadvantages of Insulin Pumps 5.1.3 Human Insulin and Analogues 5.2 Insulin Infusion Pumps Submarket, 2014 5.2.1 Insulin Pumps Submarket Regional Breakdown, 2014 5.3 Insulin Pumps Submarket: Sales Forecast, 2015-2025 5.3.1 Insulin Pumps Submarket: Sales Forecast, 2015-2019 5.3.2 Insulin Pumps Submarket: Sales Forecast, 2019-2025 5.4 Leading Products in Insulin Pumps Submarket, 2015 5.4.1 MiniMed (Medtronic) 5.4.2 OmniPod (Insulet Corporation) 5.4.3 OneTouch Ping (Animas Corporation) 5.4.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche) 5.4.5 t:Slim (Tandem Diabetes Care) 5.4.6 Animas Vibe (Animas Acquired by Johnson & Johnson) 5.4.7 DANA Diabecare IISG (SOOIL) 5.4.8 SpringZone (D. Medical Industries) 5.4.9 Cellnovo (Cellnovo) 5.4.10 V-Go (Valeritas) 5.5 Key Insulin Pumps Pipeline Products, 2015 5.5.1 Finesse Personal Insulin Patch (Johnson & Johnson) 5.5.2 SOLO MicroPump (Roche) 5.5.3 JewelPump (Debiotech) 5.5.4 Artificial Pancreas (Juvenile Diabetes Research Foundation) 5.5.5 PaQ (CeQur) 5.5.6 t:Sensor & t:Flex (Tandem Diabetes Care) 5.5.7 Freehand (MedSolve Technologies) 5.5.8 NanoPump (Debiotech) 5.5.9 PassPort (Altea Therapeutics) 5.5.10 NiliPatch (D. Medical Industries) 5.6 Insulin Pumps Submarket: Drivers and Restraints, 2015-2025 5.6.1 Increased Competition Drives Innovation 5.6.2 Collaborating to Address Unmet Needs 5.6.3 A Strong R&D Pipeline Will Drive the Market 5.6.4 Diabetes Globalisation: A Rapidly Increasing Incidence 5.6.5 Developed Economies: Increasing Adoption 5.6.6 Reimbursement of Insulin Pumps Will Give Long-Term Economic Benefits 5.6.7 More Expensive Technology Presents a Challenge When Entering Emerging Markets 5.6.8 Security Risks with Insulin Pumps
6. Enteral Feeding Pumps Submarket, 2015-2025 6.1 Introduction to Enteral Feeding Pumps 6.1.1 Clinical Settings That May Require Enteral Feeding 6.1.2 Advantages and Disadvantages of Enteral Feeding 6.1.3 Delivery of Enteral Feeding 6.1.3.1 Tube Placements Used in Enteral Feeding 6.1.4 Enteral Feeding at Home 6.2 Enteral Feeding Pumps Submarket, 2014 6.2.1 Enteral Feeding Pumps Submarket Regional Breakdown, 2014 6.3 Enteral Feeding Pumps Submarket: Sales Forecast, 2015-2025 6.3.1 Enteral Feeding Pumps Submarket: Sales Forecast, 2015-2019 6.3.2 Enteral Feeding Pumps Submarket: Sales Forecast, 2019-2025 6.4 Leading Products in Enteral Feeding Pump Submarket, 2015 6.4.1 Compat DualFlo Enteral Feeding Pump (Acquired by Medline) 6.4.2 Sentinel Enteral Feeding Pump (ALCOR Scientific) 6.4.3 EnteraLite Infinity Enteral Feeding Pump (Zevex/Moog) 6.4.4 APPLIX Vision (Fresenius Kabi) 6.4.5 MiniFlo (Fresenius Kabi) 6.4.6 Nutricia FloCare Infinity Pump (Danone Nutricia) 6.4.7 Sapphire (Q Core Medical) 6.4.8 Kangaroo Joey Enteral Feeding Pump (Covidien) 6.4.9 Other Notable Enteral Feeding Pumps 6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2015-2025 6.5.1 Cost-Effective, Portable and Safer Products will Drive Growth 6.5.2 Growing World Geriatric Population and Prevalence of Chronic Diseases 6.5.3 Increasing Demand for Homecare Solutions and Portability 6.5.4 Exit of Abbott in the US Enteral Feeding Market in 2013 6.5.5 Introduction of ISO’s Standards for Small-Bore Connectors 6.5.6 Replacement of Pumps and Sales of Disposable Feeding Sets Will Sustain Market Revenue 6.5.7 Highly Competitive Market with High Barriers to Entry
7. Other Infusion Pumps Submarket, 2015-2025 7.1 Other Infusion Pumps Submarket Definition 7.2 Other Infusion Pumps Submarket, 2014 7.3 Other Infusion Pumps Submarket: Sales Forecast, 2015-2025 7.4 Chemotherapy Pumps 7.4.1 Introduction to Chemotherapy Pumps 7.4.2 Advantages and Disadvantages of Chemotherapy Pumps 7.4.3 Leading Drugs in the Cancer Therapeutics Market, 2014 7.4.4 The Chemotherapy Pumps Market, 2015 7.4.5 Leading Products in Chemotherapy Pumps Market, 2015 7.4.5.1 Infusor Infusion Pump (Baxter) 7.4.5.2 CODMAN 3000 (Johnson & Johnson) 7.4.5.3 Optima MS (Fresenius Kabi) 7.4.5.4 CADD Legacy-1 (Smiths Medical) 7.4.5.5 Other Notable Chemotherapy Pumps 7.4. 6 Chemotherapy Pumps Market: Drivers and Restraints, 2015-2025 7.5 Patient Controlled Analgesia Pumps 7.5.1 What Are PCA Pumps? 7.5.2 Clinical Settings Where PCA Pumps Are Used 7.5.3 How Does a PCA Pump Work? 7.5.4 Advantages and Disadvantages of PCA Pumps 7.5.5 Narcotic Drugs 7.5.6 Leading Products in the PCA Pumps Market, 2015 7.5.6.1 LifeCare PCA with Hospira MedNet Software (Hospira) 7.5.6.2 Alaris PCA (CareFusion) 7.5.6.3 Baxter PCA II (Baxter) 7.5.6.4 Curlin PainSmart IOD Pain Management System (B.Braun) 7.5.6.5 CADD-Solis Infusion Pump (Smiths Medical) 7.5.6.6 Other Notable PCA Pumps 7.6 PCA Pumps Market: Drivers and Restraints, 2015-2025
8. Competing Technology Analysis, 2015-2025 8.1 Drug Delivery Technologies 8.1.1 Introduction to Drug Delivery Technologies (DDT) 8.1.2 Types of Technologies for Drug Delivery 8.1.2.1 Sustained/Controlled Release Systems 8.1.2.2 Injection 8.1.2.3 Needle Free Injections 8.1.2.4 Pulmonary, Buccal and Nasal Delivery 8.1.2.5 Pills and Capsules 8.2 World Drug Delivery Technologies Market, 2014 8.2.1 Drug Delivery Technologies Market Regional Breakdown, 2014 8.3 World Drug Delivery Technologies Market Forecast, 2015-2025 8.4 Key Drug Delivery Pipeline Products, 2015
9. Qualitative Analysis of the Infusion Pumps Market, 2015-2025 9.1 SWOT Analysis of World Infusion Pumps Market, 2015-2025 9.2 Strengths 9.2.1 Highly Accurate Dosing at Regular Intervals 9.2.2 Improved Quality of Life and Less Hospital Visits 9.2.3 Used in a Wide Range of Clinical Settings 9.3 Weaknesses 9.3.1 Safety Concerns Will Call For Stricter Regulation 9.3.2 Discomfort May Discourage Potential Users 9.3.3 Expensive Technologies May Restrain the Market 9.4 Opportunities 9.4.1 Emerging Economies Are Growing 9.4.2 Patient Demographics 9.4.3 High Demand for Technological Advancements 9.4.4 Drugs Coming Off-Patent Will Help to Drive the Market 9.5 Threats 9.5.1 Poor Economic Conditions in Key Regions of the Market 9.5.2 Cost Effectiveness May Be Difficult to Prove 9.5.3 Regulatory Bodies Can Make Entry to Market Difficult 9.5.4 Technological Advances in Drug Delivery May Surpass Those in Infusion 9.6 Porter’s Five Forces Analysis of the Infusion Pumps Market 9.6.1 Competitive Market Leaders [High] 9.6.2 Threat of New Entrants [Medium] 9.6.3 Power of Suppliers [Medium] 9.6.4 Bargaining Power of Buyers [High] 9.6.5 Threat of Substitutes [Medium]
10. Research Interviews 10.1 Interview with Prof. Charles Clark, Former Associate Dean at Indiana University School of Medicine 10.1.1 New Glucose-Analysing Programme 10.1.2 Restraints in the Chinese Insulin Pumps Market 10.1.3 Market Potentials in the Insulin Pumps Market 10.1.4 Opportunities for Infusion Pumps Manufacturers 10.1.5 Size of the Current Chinese Insulin Pumps Market 10.1.6 Challenges Facing Infusion Pumps Manufacturers in Emerging Economies 10.1.7 The Future of Insulin Pumps Market?
11. Conclusions 11.1 Infusion Pumps: A Growing Industry 11.2 Current Look at the World Infusion Pumps Market, 2015 11.3 The Global Infusion Pumps Market: Driven or Restrained?
Glossary
List of Tables Table 1.1 Infusion Pumps: Leading National Markets Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 2.1 Ideal Specification of an Infusion Pump Table 2.2 Specification of a Syringe Pump Table 2.3 Advantages and disadvantages of syringe pumps Table 2.4 Advantages and Disadvantages of Infusion Pumps Table 3.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2014-2025 Table 3.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 3.3 Market Shares (%) of Infusion Pumps by Market Segment 2014, 2019 and 2025 Table 4.1 Global Infusion Pumps Market: Revenue ($bn) and Market Shares (%) by Region, 2014 Table 4.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2014-2025 Table 4.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2014-2025 (Continued) Table 4.3 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2014-2019, 2019-2025 and 2014-2025 Table 4.4 Market Shares (%) of Infusion Pumps Market by Region, in 2014, 2019, and 2025 Table 4.5 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.6 EU Infusion Pumps Market: Revenues ($bn) and EU Market Shares (%) by Leading Countries, 2014 Table 4.7 EU Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.8 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2014-2019, 2019-2025 and 2014-2025 Table 4.9 EU Market Shares (%) of the EU Infusion Pumps Market by Leading Countries 2014, 2019, and 2025 Table 4.10 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.11 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.12 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.13 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.14 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.15 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.16 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.17 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.18 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.19 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 4.20 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 5.1 Control of Insulin Delivery (Infusion Types and Methods) Table 5.2 Advantages and Disadvantages of Insulin Pumps Table 5.3 Insulin Analogues Submarket: Leading Products by Revenue ($bn) and Market Shares (%), 2014 Table 5.4 Insulin Pumps Submarket: Revenue ($bn) and Market Shares (%) by Region, 2014 Table 5.5 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 5.8 Diabetes Prevalence (m) in Leading National Markets, 2013 Table 6.1 Advantages and Disadvantages of Enteral Feeding, 2015 Table 6.2 Types of Tubes Used in Enteral Feeding, 2015 Table 6.3 Enteral Feeding Pumps Submarket: Revenues ($bn) and Market Shares (%) by Region, 2014 Table 6.4 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 6.5 Leading Products in the Enteral Feeding Pumps Submarket, 2015 Table 6.6 Other Products in the Enteral Feeding Pumps Submarket, 2015 Table 7.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2025 Table 7.2 Advantages and Disadvantages of Chemotherapy Pumps Table 7.3 Anti-Cancer Drugs: Revenue ($bn) and Market Shares (%), 2014 Table 7.4 Top 10 Anti-Cancer Drugs: Key Facts Table 7.5 Leading Products in the Chemotherapy Pump Market, 2015 Table 7.6 Advantages and Disadvantages of PCA Pumps Table 7.7 Leading Products in the PCA Pumps Market, 2015 Table 7.8 Other Noticeable PCA Pumps Table 8.1 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Application, 2014 Table 8.2 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Country, 2014 Table 8.3 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Application, 2014-2025 Table 8.4 Key Pipeline Products for Oral Delivery, 2015 Table 8.5 Key Pipeline Products for Transdermal, Transmucosal, and Implantable Delivery, 2015 Table 8.6 Key Pipeline Products for Inhaled and Injectable Delivery, 2015 Table 9.1 SWOT Analysis of World Infusion Pumps Market 2015-2025 Table 9.2 Average Initial Costs Associated With Insulin Pump Use ($) Table 9.3 Insulin Delivery Technologies: Average Annual Costs of Usage ($) Table 9.4 Infusion Pumps and Related Products Recall in the US, 2007-2015
List of Figures Figure 1.1 Top Five National Infusion Pumps Market by Revenue ($bn), 2015 & 2025 Figure 1.2 World Infusion Pumps Market Segmentation Overview, 2015 Figure 2.1 Revision of the Medical Devices Directives Figure 3.1 World Medical Devices Market Forecast: Revenue ($bn) and AGR (%), 2014-2025 Figure 3.2 World Infusion Pumps Market Forecast: Revenue ($bn) and AGR (%), 2014-2025 Figure 3.3 World Infusion Pumps Market Forecast: Revenues ($bn) by Segment, 2015-2025 Figure 3.4 World Infusion Pumps Market: Market Shares (%) by Segment, 2014 Figure 3.5 World Infusion Pumps Market: Market Shares (%) by Segment, 2019 Figure 3.6 World Infusion Pumps Market: Market Shares (%) by Segment, 2025 Figure 3.7 World Infusion Pumps Market: Drivers and Restraints, 2015-2025 Figure 4.1 World Infusion Pumps Market: Revenue ($bn) by Region, 2014 Figure 4.2 World Infusion Pumps Market: Market Shares (%) by Region, 2014 Figure 4.3 World Infusion Pumps Market Forecast: Comparison between Revenue ($bn) and CAGR (%) by Region, 2014 and 2025 Figure 4.4 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2014-2019, 2019-2025, and 2014-2025 Figure 4.5 World Infusion Pumps Market: Market Shares (%) by Region, 2019 Figure 4.6 World Infusion Pumps Market: Market Shares (%) by Region, 2025 Figure 4.7 US 65+ Population Forecast: Size (m), 2014-2025 Figure 4.8 US Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.9 EU Infusion Pumps Market: Leading Countries by Revenue ($bn), 2014 Figure 4.10 EU Infusion Pumps Market: Leading Countries by Market Share (%), 2014 Figure 4.11 EU Infusion Pumps Market Forecast: Revenue ($bn) and AGR (%), 2014-2025 Figure 4.12 EU5 Infusion Pumps Market Forecast: Revenues ($bn) by Leading Countries, 2014-2025 Figure 4.13 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2014-2019, 2019-2025 and 2014-2025 Figure 4.14 EU Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2019 Figure 4.15 EU Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2025 Figure 4.16 Germany Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.17 French Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.18 UK Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.19 Italian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.20 Spanish Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.21 Japanese Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.22 Chinese Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.23 China’s Historical Healthcare Expenditure ($bn), 2001-2010 Figure 4.24 Chinese Population: Aged 65 or Over (million) in 1950, 2010, and 2050 Figure 4.25 Indian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.26 Brazilian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.27 South Korean Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 4.28 Russian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2014-2025 Figure 5.1 Insulin Analogues Submarket: Revenue ($bn) by Leading Products, 2014 Figure 5.2 Insulin Analogues Submarket: Leading Products by Market Shares (%), 2014 Figure 5.3 Insulin Pumps Submarket: Revenues ($bn) by Region, 2014 Figure 5.4 World Insulin Pumps Market: Market Shares (%) by Region, 2014 Figure 5.5 Insulin Pumps Submarket Forecast: Revenue ($bn) and AGR (%), 2014-2025 Table 5.6 Leading Products in the Insulin Pumps Submarket, 2015 Table 5.7 Key Pipeline Products for Insulin Pumps Submarket, 2015 Figure 5.6 Insulin Pumps Submarket: Drivers and Restraints, 2015-2025 Figure 5.7 Diabetes Prevalence (%) in Leading National Markets, 2013 Figure 6.1 Conditions That Require The Use Of Enteral Feeding Pumps, 2015 Figure 6.2 Enteral Feeding Pumps Submarket: Revenues ($bn) by Region, 2014 Figure 6.3 World Enteral Feeding Pumps Market: Market Shares (%) by Region, 2014 Figure 6.4 Enteral Feeding Pumps Submarket Forecast: Revenue ($bn) and AGR (%), 2014-2025 Figure 6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2015-2025 Figure 7.1 Other Infusion Pumps Submarket Forecast: Revenue ($bn) and AGR (%), 2014-2025 Figure 7.2 Top 10 Anti-Cancer Drugs: Revenues ($bn), 2014 Figure 7.3 Top 10 Anti-Cancer Drugs: Market Shares (%), 2014 Figure 7.4 Chemotherapy Pumps World Market: Drivers and Restraints, 2015-2025 Figure 7.5 Routes of PCA Administration Figure 7.6 PCA Pumps World Market: Drivers and Restraints, 2015-2025 Figure 8.1 World Drug Delivery Technologies Market: Revenues ($bn) by Application, 2014 Figure 8.2 World Drug Delivery Technologies Market: Market Shares (%) by Application, 2014 Figure 8.3 World Drug Delivery Technologies Market: Revenues ($bn) by Country, 2014 Figure 8.4 World Drug Delivery Technologies Market: Market Shares (%) by Country, 2014 Figure 8.5 World Drug Delivery Technologies Market Forecast: Revenue ($bn) and AGR (%), 2014-2025 Figure 8.6 World Drug Delivery Technologies Market Forecast: Revenue ($bn) by Application, 2014-2025 Figure 9.1 Insulin Delivery Technologies: Average Annual Costs of Usage ($) Figure 9.2 World Population Aged 65+ Forecast: Population (millions) and AGR (%), 2014-2025 Figure 9.3 Porter’s Five Forces Analysis of the Infusion Pumps Market, 2015-2025 Figure 11.1 Top Five National Infusion Pumps Market by Revenue ($bn), 2015 & 2025 Figure 11.2 Main Drivers and Restraints In The Global Infusion Pumps Market, 2015-2025
Abbott Nutrition Akas Medical Alcor Scientific Alkermes Allied Medical Altea Therapeutics Amsino International Animas Corporation Aradigm Asante B. Braun Baxter Bayer Healthcare Becton & Dickson & Co Bio-Med BMS Boston Scientific Corporation Calibra Medical Cardinal Health CareFusion Celgene Cellnovo Celsus Laboratories CeQur CME Medical Codman and Shurtleff Conmed Corporation Cook Medical Covidien D. Medical Industries Danone Nutricia Debiotech DePuy Disetronic Medical Systems DreaMed Diabetes Eli Lilly Emco Emisphere Fresenius Kabi GE Medical Generex Biotechnology Corporation Glycologic Hanraj Nayyar Medical India Hospira IBM I-Flow Insulet Corporation Intercell Johnson and Johnson Kimberly Clark Corporation Medingo Medsolve Technologies Medtronic Micrel Medical Devices Mindray Moog NeoDevices NeoMed Nestle Healthcare NiliMEDIX Novartis Noven Pharmaceuticals NovoNordisk Pacira Pharmaceuticals Philips Medical pSivida Corporation Q Core Medical Roche Sanofi Schiller Smith Medical SOOIL Symbios Medical Products Takeda Tandem Diabetics Care Tandem Diagnostics Terumo Medical Corporation Trivitron Valeritas Vectura Vishal Surgical WalkMed Inc Zevex
Other Organisations Mentioned in this Report Agência Nacional de Vigilância Sanitária (ANVISA) American Medical Devices and Diagnostic Association (AMDD) Center for Devices and Radiological Health (CDRH) Centres for Medicare and Medicaid Service (CMS) China Food and Drug Administration (CFDA) China’s National Health and Planning Commission (NHPC) Chinese Ministry of Science and Technology Government Accountability Office (GAO) Indiana University School of Medicine Japanese Ministry of Health, Labour and Welfare (MHLW) Juvenile Diabetes Research Foundation Medical Devices Information & Technology Assistance Centre (MDITAC) Medicines and Healthcare products Regulatory Agency (MHRA) National Competent Authorities (NCAs) National Diabetes Education Program (NDEP) National Institute for Health and Clinical Excellence (NICE) National Medical Devices Authority (NMDA) NHS England Ningbo First Hospital Roszdravnadzor Sahlgrenska Academy Servicio Sanitario Nazionale (SSN) South Korean Ministry for Food and Drug Safety (MFDS) South Korean Ministry of Health and Welfare (MOHW) South Korean Ministry of Science, ICT and Future Planning (MSIP) South Korean Ministry of Trade, Industry and Energy (MOTIE) Único de Saúde (SUS) United Nations Population Division United States Food and Drug Administration (FDA) US Department of Health and Human Services World Bank World Health Organization (WHO) Zhejiang Hospital
Download sample pages
Complete the form below to download your free sample pages for Infusion Pumps Market: Prospects for Leading Companies 2015-2025
Download sample pages
Complete the form below to download your free sample pages for Infusion Pumps Market: Prospects for Leading Companies 2015-2025
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.
The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.
The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet
The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
